Omschrijving
Dr. Sonis is senior academic at Harvard, Brigham and Women's Hospital and the Dana-Farber Cancer Institute and a world-renowned expert in epithelial injury associated with cancer therapy. His development of predictive animal models has enabled the investigation of the biological basis of cancer regimen-related epithelial injury and has catalyzed the development of potential therapies. Dr. Sonis' interest in the genomic basis for toxicity risk and its pathology has led to innovative genomics-based analytical approaches to clinically actionable outcomes to personalize disease therapy. He has published extensively on the clinical, biological, and health economic aspects of cancer and complications associated with its treatment. Steve holds several patents and is the author of more than 275 original publications, reviews, and chapters and is completing his eleventh book. He obtained degrees from Tufts and Harvard and completed his post-doctoral education (tumor immunology) at Oxford University where he was a Knox Fellow. Dr. Magee is a graduate of the University of Connecticut School of Dental Medicine. She completed the Brigham and Women's Hospital Harvard-wide General Practice Residency in Dentistry, and then a Fellowship in Hospital Dentistry at Mass General prior to joining the Mass General faculty in 2009. She has a passion for improving access to dental care for underserved populations, which led her to pursue a Master's in Public Health in 2010 from the Harvard School of Public Health. She was recognized by the Massachusetts Dental Society in 2015 as "10 under 10" in recognition of significant contributions to the profession, her community and organized dentistry. She has consistently earned Boston Magazine 'Top Dentists' distinction as voted on by her peers. Her practice focuses on medically complex adult and pediatric patients, trauma survivors and those with special needs. She aims to create a clinical space where all feel safe and welcome to ensure they receive a lifetime of quality oral health care.
Dr. Sonis is senior academic at Harvard, Brigham and Women's Hospital and the Dana-Farber Cancer Institute and a world-renowned expert in epithelial injury associated with cancer therapy. His development of predictive animal models has enabled the investigation of the biological basis of cancer regimen-related epithelial injury and has catalyzed the development of potential therapies. Dr. Sonis' interest in the genomic basis for toxicity risk and its pathology has led to innovative genomics-based analytical approaches to clinically actionable outcomes to personalize disease therapy. He has published extensively on the clinical, biological, and health economic aspects of cancer and complications associated with its treatment. Steve holds several patents and is the author of more than 275 original publications, reviews, and chapters and is completing his eleventh book. He obtained degrees from Tufts and Harvard and completed his post-doctoral education (tumor immunology) at Oxford University where he was a Knox Fellow. Dr. Magee is a graduate of the University of Connecticut School of Dental Medicine. She completed the Brigham and Women's Hospital Harvard-wide General Practice Residency in Dentistry, and then a Fellowship in Hospital Dentistry at Mass General prior to joining the Mass General faculty in 2009. She has a passion for improving access to dental care for underserved populations, which led her to pursue a Master's in Public Health in 2010 from the Harvard School of Public Health. She was recognized by the Massachusetts Dental Society in 2015 as "10 under 10" in recognition of significant contributions to the profession, her community and organized dentistry. She has consistently earned Boston Magazine 'Top Dentists' distinction as voted on by her peers. Her practice focuses on medically complex adult and pediatric patients, trauma survivors and those with special needs. She aims to create a clinical space where all feel safe and welcome to ensure they receive a lifetime of quality oral health care.